A study for a 23 year old woman who takes Xarelto - from FDA reports


Summary

443 females aged 23 (±5) who take the same drug are studied. This is a personalized study for a 23 year old female patient who has Dvt. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 06, 2017

443 females aged 23 (±5) who take Xarelto are studied.


Number of reports submitted per year:

Xarelto for a 23-year old woman.

Information of the patient in this study:

  • Age: 23
  • Gender: female
  • Conditions: Dvt
  • Drugs taken:
    • Xarelto (rivaroxaban)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Constipation: 5 (1.13% of females aged 23 (±5) who take the drug)
  • Thirst: 0 (0% of females aged 23 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  • vaginal haemorrhage
  • pulmonary embolism
  • heavy or prolong menstrual bleeding
  • dizziness
  • headache
  • drug ineffective
  • rectal haemorrhage
  • gastrointestinal haemorrhage
  • nausea
  • breathing difficulty
1 - 6 months:
  • gastrointestinal haemorrhage
  • vaginal haemorrhage
  • headache
  • pulmonary embolism
  • rectal haemorrhage
  • heavy or prolong menstrual bleeding
  • malaise
  • uterine haemorrhage
  • right ventricular failure
  • haemorrhage
6 - 12 months:
  • haemorrhage
  • groin pain
  • abdominal distension
  • abdominal pain upper
  • abdominal pain lower
  • abortion spontaneous
  • heavy or prolong menstrual bleeding
  • gastrointestinal haemorrhage
  • gingival bleeding
  • diarrhea haemorrhagic
1 - 2 years:
  • heavy or prolong menstrual bleeding
  • gastrointestinal haemorrhage
  • peritoneal haemorrhage
  • ischaemic stroke
  • treatment failure
  • pulmonary embolism
  • iron deficiency anaemia
  • lower gastrointestinal haemorrhage
  • haemorrhoidal haemorrhage
2 - 5 years:
  • dysfunctional uterine bleeding (dub)
  • dysmenorrhea
  • gastrointestinal haemorrhage
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • pulmonary embolism
  • heavy or prolong menstrual bleeding
  • drug ineffective
  • breathing difficulty
  • nausea
  • chest pain
  • headache
  • thrombosis
  • hair loss
  • vaginal haemorrhage

Top conditions involved for these people *:

  • Pulmonary Embolism (126 people, 28.44%)
  • Embolism Venous (57 people, 12.87%)
  • Birth Control (32 people, 7.22%)
  • Thrombosis (22 people, 4.97%)
  • Primary Pulmonary Hypertension (19 people, 4.29%)

Top co-used drugs for these people *:

  • Heparin (17 people, 3.84%)
  • Adcirca (17 people, 3.84%)
  • Coumadin (16 people, 3.61%)
  • Letairis (13 people, 2.93%)
  • Lovenox (11 people, 2.48%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Dvt, Xarelto, Constipation, Thirst

You may be interested in these reviews

More reviews for: Dvt, Xarelto, Constipation, Thirst